Kingdon Capital Management
Overview
Kingdon Capital Management is a US-based hedge fund manager founded in 1983 that employs global long/short equity and healthcare-focused investment strategies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mighty Therapeutics | Jun 2018 | Convertible Debt | Co-investor |
| CeQur | Apr 2021 | Series C Extension | Co-investor |
| Sapience Therapeutics | May 2022 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kingdon Capital Management based?
Kingdon Capital Management is headquartered in New York City, New York, United States.
When was Kingdon Capital Management founded?
Kingdon Capital Management was founded in 1983.
How many portfolio companies does Kingdon Capital Management have?
Kingdon Capital Management has 5 portfolio companies in Caplight's dataset.
What are some companies in Kingdon Capital Management's portfolio?
Portfolio companies visible on Caplight include Mighty Therapeutics, CeQur, Sapience Therapeutics.
What was Kingdon Capital Management's most recent investment shown here?
Kingdon Capital Management's most recent investment in this portfolio sample was in Sapience Therapeutics in 2022.
What sectors does Kingdon Capital Management focus on?
Kingdon Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Kingdon Capital Management focus on?
Kingdon Capital Management typically invests at the Mid stage.